A company still losing money with growing sales, with high risk.
Facts from SEC filings, not a recommendation.
Last 12 months: $51.8M, up 18% from the 12 months before.
Price chart by TradingView.
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+. A checklist is a starting point for research, not a verdict.
50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.
SEC filings of any kind. 50 means a normal week.
Institutions added 2.7% to their holdings. 5 bought, 8 sold.
| Insider | Trade | Shares | Avg price | Value | Owns after | Date |
|---|---|---|---|---|---|---|
Kathleen ValiasekPresident and CEO | Sell | 119K | $1.06 | $126K | 1M | Oct 2Filing ↗ |
| ||||||
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
118,720 shares at $1.06 · $126K
1,000,000 shares
118,720 shares at $1.30 · $154K
62,949 shares
62,949 shares
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page